TMPRSS2 and hepatocellular carcinoma: Another research reveals that the levels of transmembrane serine protease 2 (TMPRSS2) in tumors are conversely correlated with the NID1 levels in EVs, indicating that inactivating TMPRSS2 can counteract the malignant characteristics of HCC [95].